Umoja Biopharma Patents – Insights & Stats (Updated 2023)

Umoja Biopharma has a total of 59 patents globally, out of which no patents have been granted. Of these 59 patents, more than 88% patents are active. Europe is where Umoja Biopharma has filed the maximum number of patents, followed by Canada and Singapore. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Umoja Biopharma.

Umoja Biopharma was founded in the year 2019. The Company operates as a biotechnology company. The Company offers healthcare platform for transformation of cancer treatment.

Do read about some of the most popular patents of Umoja Biopharma which have been covered by us in this article and also you can find Umoja Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Umoja Biopharma patent portfolio.

How many patents does Umoja Biopharma have?

Umoja Biopharma has a total of 59 patents globally. These patents belong to 12 unique patent families. Out of 59 patents, 52 patents are active.

How Many Patents did Umoja Biopharma File Every Year?

Umoja Biopharma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantUmoja Biopharma Applications FiledUmoja Biopharma Patents Granted
20238
20229
202122
20209
201911

How many Umoja Biopharma patents are Alive/Dead?

Umoja Biopharma Patent Portfolio

How Many Patents did Umoja Biopharma File in Different Countries?

Umoja Biopharma Worldwide Patent Filing

Countries in which Umoja Biopharma Filed Patents

CountryPatents
Europe7
Canada5
Singapore5
Australia5
Israel5
Korea (South)4
United States of America4
New Zealand4
Hong Kong (S.A.R.)3
Brazil3
Mexico2

Where are Research Centres of Umoja Biopharma Patents Located?

The Research Centre for all the Umoja Biopharma patents is the United States of America.

Best Umoja Biopharma Patents

WO2022109162A1 is the most popular patent in the Umoja Biopharma portfolio. It has received 4 citations so far from company like Endocyte.

What Percentage of Umoja Biopharma US Patent Applications were Granted?

Umoja Biopharma (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.

Below are the key stats of Umoja Biopharma patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Umoja Biopharma?

Law FirmTotal ApplicationsSuccess Rate
Mintz Levin Boston Office10%

What are Umoja Biopharma key innovation segments?

What Technologies are Covered by Umoja Biopharma?

The chart below distributes patents filed by Umoja Biopharma in different countries on the basis of the technology protected in patents. It also represents the markets where Umoja Biopharma thinks it’s important to protect particular technology inventions.

R&D Focus: How has Umoja Biopharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Umoja Biopharma?

Related Articles

Celcem Patents – Insights & Stats (Updated 2024)

Celcem has a total of 28 patents globally, out of which all patents have been granted. Of these 28 patents, all patents patents are active. Singapore is where Celcem has filed the maximum number of patents. Parallelly, Singapore seems to be the main focused R&D centre and also is the

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.